Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery

NCT05147233 is registered in ClinicalTrials.gov with Oculis as lead sponsor.

NCT NCT05147233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05147233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery
Lead sponsor
Oculis
Phase
Phase 3
Overall status
Completed
Start date
June 24, 2022
Completion date
July 3, 2023
Enrollment
241 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation eye pain, postoperative cataract